Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury

Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated... Pharm Res (2018) 35:94 https://doi.org/10.1007/s11095-018-2366-9 RESEARCH PAPER Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury 1 2 3 Hari R. Desu & Laura A. Thoma & George C. Wood Received: 20 October 2017 /Accepted: 10 February 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT tract, especially alveolar region, Among the formulations, cRGD Purpose Acute lung injury (ALI) is a fatal syndrome in criti- MPS-L caused significant reduction of edema, neutro- cally ill patients. It is characterized by lung edema and inflam- phil infiltration and inflammation biochemical marker levels. mation. Numerous pro-inflammatory mediators are released Conclusion From the results, it can be inferred that nebuliza- into alveoli. Among them, interleukin-1beta (IL-1β)causesan tion of targeted liposomes had facilitated spatial and temporal increase in solute permeability across the alveolar-capillary modulation of drug delivery resulting in alleviation of ALI. barrier leading to edema. It activates key effector cells (alveo- lar epithelial and endothelial cells) releasing inflammatory . . . KEY WORDS drug delivery formulation inflammation chemokines and cytokines. The purpose of the study was to demonstrate that nebulized liposomes inhibit ALI in vivo. liposome nebulization Methods In vivo ALI model was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmaceutical Research Springer Journals

Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury

Loading next page...
 
/lp/springer_journal/nebulization-of-cyclic-arginine-glycine-d-aspartic-acid-peptide-0tTf3S7b7L
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Biomedicine; Pharmacology/Toxicology; Pharmacy; Biochemistry, general; Medical Law; Biomedical Engineering
ISSN
0724-8741
eISSN
1573-904X
D.O.I.
10.1007/s11095-018-2366-9
Publisher site
See Article on Publisher Site

Abstract

Pharm Res (2018) 35:94 https://doi.org/10.1007/s11095-018-2366-9 RESEARCH PAPER Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury 1 2 3 Hari R. Desu & Laura A. Thoma & George C. Wood Received: 20 October 2017 /Accepted: 10 February 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 ABSTRACT tract, especially alveolar region, Among the formulations, cRGD Purpose Acute lung injury (ALI) is a fatal syndrome in criti- MPS-L caused significant reduction of edema, neutro- cally ill patients. It is characterized by lung edema and inflam- phil infiltration and inflammation biochemical marker levels. mation. Numerous pro-inflammatory mediators are released Conclusion From the results, it can be inferred that nebuliza- into alveoli. Among them, interleukin-1beta (IL-1β)causesan tion of targeted liposomes had facilitated spatial and temporal increase in solute permeability across the alveolar-capillary modulation of drug delivery resulting in alleviation of ALI. barrier leading to edema. It activates key effector cells (alveo- lar epithelial and endothelial cells) releasing inflammatory . . . KEY WORDS drug delivery formulation inflammation chemokines and cytokines. The purpose of the study was to demonstrate that nebulized liposomes inhibit ALI in vivo. liposome nebulization Methods In vivo ALI model was

Journal

Pharmaceutical ResearchSpringer Journals

Published: Mar 13, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial